nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Dinoprost Tromethamine—HPGDS—lung cancer	0.00993	0.472	CrCbGaD
Carboprost Tromethamine—Dinoprostone—HPGDS—lung cancer	0.00764	0.363	CrCbGaD
Carboprost Tromethamine—Tafluprost—PTGS2—lung cancer	0.00347	0.165	CrCbGaD
Carboprost Tromethamine—Asthenia—Erlotinib—lung cancer	0.000978	0.00124	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Irinotecan—lung cancer	0.000972	0.00123	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vinblastine—lung cancer	0.00097	0.00123	CcSEcCtD
Carboprost Tromethamine—Infection—Irinotecan—lung cancer	0.000966	0.00122	CcSEcCtD
Carboprost Tromethamine—Back pain—Etoposide—lung cancer	0.000958	0.00122	CcSEcCtD
Carboprost Tromethamine—Shock—Irinotecan—lung cancer	0.000956	0.00121	CcSEcCtD
Carboprost Tromethamine—Tension—Paclitaxel—lung cancer	0.000953	0.00121	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Etoposide—lung cancer	0.000952	0.00121	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Gemcitabine—lung cancer	0.000947	0.0012	CcSEcCtD
Carboprost Tromethamine—Eye pain—Doxorubicin—lung cancer	0.000945	0.0012	CcSEcCtD
Carboprost Tromethamine—Nervousness—Paclitaxel—lung cancer	0.000943	0.0012	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Topotecan—lung cancer	0.000943	0.0012	CcSEcCtD
Carboprost Tromethamine—Infection—Gemcitabine—lung cancer	0.000941	0.00119	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Irinotecan—lung cancer	0.00094	0.00119	CcSEcCtD
Carboprost Tromethamine—Back pain—Paclitaxel—lung cancer	0.00094	0.00119	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vinblastine—lung cancer	0.000938	0.00119	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Paclitaxel—lung cancer	0.000934	0.00118	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Erlotinib—lung cancer	0.000933	0.00118	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Vinorelbine—lung cancer	0.000932	0.00118	CcSEcCtD
Carboprost Tromethamine—Myalgia—Cisplatin—lung cancer	0.000921	0.00117	CcSEcCtD
Carboprost Tromethamine—Anxiety—Cisplatin—lung cancer	0.000917	0.00116	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Paclitaxel—lung cancer	0.000915	0.00116	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Gemcitabine—lung cancer	0.000915	0.00116	CcSEcCtD
Carboprost Tromethamine—Hot flush—Doxorubicin—lung cancer	0.000912	0.00116	CcSEcCtD
Carboprost Tromethamine—Dizziness—Topotecan—lung cancer	0.000911	0.00116	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Doxorubicin—lung cancer	0.000904	0.00115	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vinblastine—lung cancer	0.000902	0.00114	CcSEcCtD
Carboprost Tromethamine—Dizziness—Erlotinib—lung cancer	0.000901	0.00114	CcSEcCtD
Carboprost Tromethamine—Vertigo—Etoposide—lung cancer	0.00089	0.00113	CcSEcCtD
Carboprost Tromethamine—Headache—Vinblastine—lung cancer	0.000888	0.00113	CcSEcCtD
Carboprost Tromethamine—Angioedema—Paclitaxel—lung cancer	0.000888	0.00113	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Cisplatin—lung cancer	0.000882	0.00112	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000882	0.00112	CcSEcCtD
Carboprost Tromethamine—Flushing—Docetaxel—lung cancer	0.000878	0.00111	CcSEcCtD
Carboprost Tromethamine—Infection—Cisplatin—lung cancer	0.000877	0.00111	CcSEcCtD
Carboprost Tromethamine—Vomiting—Topotecan—lung cancer	0.000876	0.00111	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Irinotecan—lung cancer	0.000873	0.00111	CcSEcCtD
Carboprost Tromethamine—Vertigo—Paclitaxel—lung cancer	0.000873	0.00111	CcSEcCtD
Carboprost Tromethamine—Syncope—Paclitaxel—lung cancer	0.000871	0.0011	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Etoposide—lung cancer	0.000871	0.0011	CcSEcCtD
Carboprost Tromethamine—Lethargy—Doxorubicin—lung cancer	0.000871	0.0011	CcSEcCtD
Carboprost Tromethamine—Rash—Topotecan—lung cancer	0.000869	0.0011	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Vinorelbine—lung cancer	0.000868	0.0011	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Topotecan—lung cancer	0.000868	0.0011	CcSEcCtD
Carboprost Tromethamine—Vomiting—Erlotinib—lung cancer	0.000867	0.0011	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Irinotecan—lung cancer	0.000867	0.0011	CcSEcCtD
Carboprost Tromethamine—Cough—Etoposide—lung cancer	0.000864	0.0011	CcSEcCtD
Carboprost Tromethamine—Somnolence—Irinotecan—lung cancer	0.000864	0.0011	CcSEcCtD
Carboprost Tromethamine—Headache—Topotecan—lung cancer	0.000863	0.00109	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000863	0.00109	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Cisplatin—lung cancer	0.000861	0.00109	CcSEcCtD
Carboprost Tromethamine—Rash—Erlotinib—lung cancer	0.000859	0.00109	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Erlotinib—lung cancer	0.000859	0.00109	CcSEcCtD
Carboprost Tromethamine—Palpitations—Paclitaxel—lung cancer	0.000858	0.00109	CcSEcCtD
Carboprost Tromethamine—Hypertension—Etoposide—lung cancer	0.000855	0.00108	CcSEcCtD
Carboprost Tromethamine—Headache—Erlotinib—lung cancer	0.000854	0.00108	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Paclitaxel—lung cancer	0.000854	0.00108	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Cisplatin—lung cancer	0.000853	0.00108	CcSEcCtD
Carboprost Tromethamine—Asthma—Methotrexate—lung cancer	0.000852	0.00108	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Gemcitabine—lung cancer	0.00085	0.00108	CcSEcCtD
Carboprost Tromethamine—Chills—Docetaxel—lung cancer	0.000849	0.00108	CcSEcCtD
Carboprost Tromethamine—Cough—Paclitaxel—lung cancer	0.000848	0.00107	CcSEcCtD
Carboprost Tromethamine—Asthenia—Vinorelbine—lung cancer	0.000846	0.00107	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Gemcitabine—lung cancer	0.000844	0.00107	CcSEcCtD
Carboprost Tromethamine—Chest pain—Etoposide—lung cancer	0.000843	0.00107	CcSEcCtD
Carboprost Tromethamine—Nausea—Vinblastine—lung cancer	0.000842	0.00107	CcSEcCtD
Carboprost Tromethamine—Somnolence—Gemcitabine—lung cancer	0.000842	0.00107	CcSEcCtD
Carboprost Tromethamine—Hypertension—Paclitaxel—lung cancer	0.000839	0.00106	CcSEcCtD
Carboprost Tromethamine—Pain—Irinotecan—lung cancer	0.000831	0.00105	CcSEcCtD
Carboprost Tromethamine—Myalgia—Paclitaxel—lung cancer	0.000827	0.00105	CcSEcCtD
Carboprost Tromethamine—Chest pain—Paclitaxel—lung cancer	0.000827	0.00105	CcSEcCtD
Carboprost Tromethamine—Anxiety—Paclitaxel—lung cancer	0.000824	0.00105	CcSEcCtD
Carboprost Tromethamine—Nausea—Topotecan—lung cancer	0.000818	0.00104	CcSEcCtD
Carboprost Tromethamine—Pain—Gemcitabine—lung cancer	0.00081	0.00103	CcSEcCtD
Carboprost Tromethamine—Nausea—Erlotinib—lung cancer	0.00081	0.00103	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Etoposide—lung cancer	0.000808	0.00103	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vinorelbine—lung cancer	0.000806	0.00102	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000804	0.00102	CcSEcCtD
Carboprost Tromethamine—Infection—Etoposide—lung cancer	0.000803	0.00102	CcSEcCtD
Carboprost Tromethamine—Back pain—Docetaxel—lung cancer	0.000796	0.00101	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000793	0.00101	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Cisplatin—lung cancer	0.000792	0.001	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Docetaxel—lung cancer	0.000792	0.001	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Methotrexate—lung cancer	0.000791	0.001	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Etoposide—lung cancer	0.000789	0.001	CcSEcCtD
Carboprost Tromethamine—Infection—Paclitaxel—lung cancer	0.000788	0.000999	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Cisplatin—lung cancer	0.000787	0.000998	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Etoposide—lung cancer	0.000782	0.000991	CcSEcCtD
Carboprost Tromethamine—Shock—Paclitaxel—lung cancer	0.00078	0.000989	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vinorelbine—lung cancer	0.000779	0.000988	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Doxorubicin—lung cancer	0.000779	0.000988	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Paclitaxel—lung cancer	0.000774	0.000981	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Irinotecan—lung cancer	0.000768	0.000974	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Paclitaxel—lung cancer	0.000766	0.000972	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Methotrexate—lung cancer	0.000759	0.000963	CcSEcCtD
Carboprost Tromethamine—Pain—Cisplatin—lung cancer	0.000755	0.000957	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vinorelbine—lung cancer	0.000749	0.00095	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Gemcitabine—lung cancer	0.000748	0.000949	CcSEcCtD
Carboprost Tromethamine—Rash—Vinorelbine—lung cancer	0.000743	0.000942	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Vinorelbine—lung cancer	0.000742	0.000941	CcSEcCtD
Carboprost Tromethamine—Headache—Vinorelbine—lung cancer	0.000738	0.000936	CcSEcCtD
Carboprost Tromethamine—Syncope—Docetaxel—lung cancer	0.000738	0.000936	CcSEcCtD
Carboprost Tromethamine—Asthma—Doxorubicin—lung cancer	0.000737	0.000935	CcSEcCtD
Carboprost Tromethamine—Palpitations—Docetaxel—lung cancer	0.000728	0.000923	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Etoposide—lung cancer	0.000726	0.000921	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Docetaxel—lung cancer	0.000724	0.000918	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000722	0.000916	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Etoposide—lung cancer	0.000721	0.000914	CcSEcCtD
Carboprost Tromethamine—Somnolence—Etoposide—lung cancer	0.000719	0.000911	CcSEcCtD
Carboprost Tromethamine—Cough—Docetaxel—lung cancer	0.000718	0.000911	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Methotrexate—lung cancer	0.000716	0.000908	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Irinotecan—lung cancer	0.000716	0.000908	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Paclitaxel—lung cancer	0.000712	0.000903	CcSEcCtD
Carboprost Tromethamine—Hypertension—Docetaxel—lung cancer	0.000711	0.000901	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Paclitaxel—lung cancer	0.000707	0.000896	CcSEcCtD
Carboprost Tromethamine—Somnolence—Paclitaxel—lung cancer	0.000705	0.000894	CcSEcCtD
Carboprost Tromethamine—Myalgia—Docetaxel—lung cancer	0.000701	0.000889	CcSEcCtD
Carboprost Tromethamine—Chest pain—Docetaxel—lung cancer	0.000701	0.000889	CcSEcCtD
Carboprost Tromethamine—Nausea—Vinorelbine—lung cancer	0.0007	0.000888	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Cisplatin—lung cancer	0.000698	0.000885	CcSEcCtD
Carboprost Tromethamine—Asthenia—Irinotecan—lung cancer	0.000697	0.000884	CcSEcCtD
Carboprost Tromethamine—Pain—Etoposide—lung cancer	0.000691	0.000877	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000685	0.000869	CcSEcCtD
Carboprost Tromethamine—Asthenia—Gemcitabine—lung cancer	0.000679	0.000861	CcSEcCtD
Carboprost Tromethamine—Pain—Paclitaxel—lung cancer	0.000678	0.00086	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Docetaxel—lung cancer	0.000672	0.000852	CcSEcCtD
Carboprost Tromethamine—Infection—Docetaxel—lung cancer	0.000668	0.000846	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Irinotecan—lung cancer	0.000665	0.000843	CcSEcCtD
Carboprost Tromethamine—Shock—Docetaxel—lung cancer	0.000661	0.000838	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Doxorubicin—lung cancer	0.000657	0.000834	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Docetaxel—lung cancer	0.000656	0.000832	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Cisplatin—lung cancer	0.00065	0.000825	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Gemcitabine—lung cancer	0.000648	0.000822	CcSEcCtD
Carboprost Tromethamine—Dizziness—Irinotecan—lung cancer	0.000643	0.000815	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Etoposide—lung cancer	0.000639	0.00081	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Doxorubicin—lung cancer	0.000639	0.00081	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Methotrexate—lung cancer	0.000636	0.000806	CcSEcCtD
Carboprost Tromethamine—Asthenia—Cisplatin—lung cancer	0.000633	0.000803	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Paclitaxel—lung cancer	0.000627	0.000795	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Doxorubicin—lung cancer	0.00062	0.000786	CcSEcCtD
Carboprost Tromethamine—Vomiting—Irinotecan—lung cancer	0.000618	0.000784	CcSEcCtD
Carboprost Tromethamine—Rash—Irinotecan—lung cancer	0.000613	0.000777	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Irinotecan—lung cancer	0.000612	0.000776	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000612	0.000776	CcSEcCtD
Carboprost Tromethamine—Chills—Methotrexate—lung cancer	0.000612	0.000776	CcSEcCtD
Carboprost Tromethamine—Headache—Irinotecan—lung cancer	0.000609	0.000772	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Cisplatin—lung cancer	0.000604	0.000766	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Docetaxel—lung cancer	0.000603	0.000765	CcSEcCtD
Carboprost Tromethamine—Vomiting—Gemcitabine—lung cancer	0.000602	0.000763	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Docetaxel—lung cancer	0.000599	0.00076	CcSEcCtD
Carboprost Tromethamine—Somnolence—Docetaxel—lung cancer	0.000597	0.000757	CcSEcCtD
Carboprost Tromethamine—Rash—Gemcitabine—lung cancer	0.000597	0.000757	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Gemcitabine—lung cancer	0.000596	0.000756	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Etoposide—lung cancer	0.000596	0.000755	CcSEcCtD
Carboprost Tromethamine—Headache—Gemcitabine—lung cancer	0.000593	0.000752	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Paclitaxel—lung cancer	0.000584	0.000741	CcSEcCtD
Carboprost Tromethamine—Asthenia—Etoposide—lung cancer	0.00058	0.000736	CcSEcCtD
Carboprost Tromethamine—Nausea—Irinotecan—lung cancer	0.000577	0.000732	CcSEcCtD
Carboprost Tromethamine—Pain—Docetaxel—lung cancer	0.000575	0.000729	CcSEcCtD
Carboprost Tromethamine—Back pain—Methotrexate—lung cancer	0.000574	0.000728	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNG11—lung cancer	0.000574	0.00301	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000571	0.003	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Paclitaxel—lung cancer	0.000569	0.000721	CcSEcCtD
Carboprost Tromethamine—Nausea—Gemcitabine—lung cancer	0.000562	0.000713	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNG11—lung cancer	0.000561	0.00295	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Cisplatin—lung cancer	0.000561	0.000712	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000559	0.00294	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Methotrexate—lung cancer	0.000559	0.000709	CcSEcCtD
Carboprost Tromethamine—Rash—Cisplatin—lung cancer	0.000556	0.000706	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—OXTR—lung cancer	0.000556	0.00292	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GRP—lung cancer	0.000556	0.00292	CbGpPWpGaD
Carboprost Tromethamine—Dermatitis—Cisplatin—lung cancer	0.000556	0.000705	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Etoposide—lung cancer	0.000553	0.000701	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Doxorubicin—lung cancer	0.00055	0.000698	CcSEcCtD
Carboprost Tromethamine—Flushing—Doxorubicin—lung cancer	0.000548	0.000695	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—OXTR—lung cancer	0.000545	0.00286	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GRP—lung cancer	0.000545	0.00286	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Paclitaxel—lung cancer	0.000542	0.000688	CcSEcCtD
Carboprost Tromethamine—Dizziness—Etoposide—lung cancer	0.000535	0.000678	CcSEcCtD
Carboprost Tromethamine—Vertigo—Methotrexate—lung cancer	0.000533	0.000676	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Docetaxel—lung cancer	0.000531	0.000674	CcSEcCtD
Carboprost Tromethamine—Chills—Doxorubicin—lung cancer	0.00053	0.000672	CcSEcCtD
Carboprost Tromethamine—Dizziness—Paclitaxel—lung cancer	0.000524	0.000665	CcSEcCtD
Carboprost Tromethamine—Nausea—Cisplatin—lung cancer	0.000524	0.000665	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNG11—lung cancer	0.000521	0.00274	CbGpPWpGaD
Carboprost Tromethamine—Cough—Methotrexate—lung cancer	0.000518	0.000657	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADCY1—lung cancer	0.000516	0.00271	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Etoposide—lung cancer	0.000514	0.000652	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000513	0.0027	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNG11—lung cancer	0.00051	0.00268	CbGpPWpGaD
Carboprost Tromethamine—Rash—Etoposide—lung cancer	0.00051	0.000646	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Etoposide—lung cancer	0.000509	0.000646	CcSEcCtD
Carboprost Tromethamine—Headache—Etoposide—lung cancer	0.000506	0.000642	CcSEcCtD
Carboprost Tromethamine—Myalgia—Methotrexate—lung cancer	0.000505	0.000641	CcSEcCtD
Carboprost Tromethamine—Chest pain—Methotrexate—lung cancer	0.000505	0.000641	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADCY1—lung cancer	0.000505	0.00265	CbGpPWpGaD
Carboprost Tromethamine—Tension—Doxorubicin—lung cancer	0.000504	0.000639	CcSEcCtD
Carboprost Tromethamine—Vomiting—Paclitaxel—lung cancer	0.000504	0.000639	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000502	0.00264	CbGpPWpGaD
Carboprost Tromethamine—Rash—Paclitaxel—lung cancer	0.0005	0.000634	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Paclitaxel—lung cancer	0.000499	0.000633	CcSEcCtD
Carboprost Tromethamine—Nervousness—Doxorubicin—lung cancer	0.000499	0.000633	CcSEcCtD
Carboprost Tromethamine—Back pain—Doxorubicin—lung cancer	0.000497	0.00063	CcSEcCtD
Carboprost Tromethamine—Headache—Paclitaxel—lung cancer	0.000497	0.00063	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Docetaxel—lung cancer	0.000495	0.000628	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Doxorubicin—lung cancer	0.000494	0.000626	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Methotrexate—lung cancer	0.000484	0.000614	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Doxorubicin—lung cancer	0.000484	0.000614	CcSEcCtD
Carboprost Tromethamine—Asthenia—Docetaxel—lung cancer	0.000482	0.000611	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—COL4A2—lung cancer	0.000482	0.00253	CbGpPWpGaD
Carboprost Tromethamine—Infection—Methotrexate—lung cancer	0.000481	0.00061	CcSEcCtD
Carboprost Tromethamine—Nausea—Etoposide—lung cancer	0.00048	0.000609	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTHLH—lung cancer	0.000479	0.00252	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—COL4A2—lung cancer	0.000471	0.00248	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Paclitaxel—lung cancer	0.000471	0.000597	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GIPR—lung cancer	0.000469	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTHLH—lung cancer	0.000469	0.00246	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADCY1—lung cancer	0.000468	0.00246	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Methotrexate—lung cancer	0.000468	0.000594	CcSEcCtD
Carboprost Tromethamine—Vertigo—Doxorubicin—lung cancer	0.000462	0.000585	CcSEcCtD
Carboprost Tromethamine—Syncope—Doxorubicin—lung cancer	0.000461	0.000584	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Docetaxel—lung cancer	0.00046	0.000583	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GIPR—lung cancer	0.000459	0.00241	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADCY1—lung cancer	0.000458	0.00241	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PPP2R1B—lung cancer	0.000456	0.0024	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Doxorubicin—lung cancer	0.000454	0.000576	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Doxorubicin—lung cancer	0.000452	0.000573	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ANXA1—lung cancer	0.000451	0.00237	CbGpPWpGaD
Carboprost Tromethamine—Cough—Doxorubicin—lung cancer	0.000448	0.000569	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PPP2R1B—lung cancer	0.000447	0.00235	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Docetaxel—lung cancer	0.000444	0.000563	CcSEcCtD
Carboprost Tromethamine—Hypertension—Doxorubicin—lung cancer	0.000444	0.000563	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ANXA1—lung cancer	0.000441	0.00232	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000441	0.00056	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SDC4—lung cancer	0.000438	0.0023	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Doxorubicin—lung cancer	0.000437	0.000555	CcSEcCtD
Carboprost Tromethamine—Myalgia—Doxorubicin—lung cancer	0.000437	0.000555	CcSEcCtD
Carboprost Tromethamine—Anxiety—Doxorubicin—lung cancer	0.000436	0.000553	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTHLH—lung cancer	0.000435	0.00229	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Methotrexate—lung cancer	0.000435	0.000551	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Methotrexate—lung cancer	0.000432	0.000548	CcSEcCtD
Carboprost Tromethamine—Somnolence—Methotrexate—lung cancer	0.000431	0.000546	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.00043	0.00226	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DUSP3—lung cancer	0.000429	0.00225	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SDC4—lung cancer	0.000429	0.00225	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—APP—lung cancer	0.000427	0.00224	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Docetaxel—lung cancer	0.000427	0.000542	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTHLH—lung cancer	0.000426	0.00224	CbGpPWpGaD
Carboprost Tromethamine—Rash—Docetaxel—lung cancer	0.000424	0.000537	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Docetaxel—lung cancer	0.000423	0.000537	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RHEB—lung cancer	0.000421	0.00221	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000421	0.00221	CbGpPWpGaD
Carboprost Tromethamine—Headache—Docetaxel—lung cancer	0.000421	0.000534	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DUSP3—lung cancer	0.00042	0.00221	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000419	0.000532	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—APP—lung cancer	0.000418	0.0022	CbGpPWpGaD
Carboprost Tromethamine—Infection—Doxorubicin—lung cancer	0.000417	0.000528	CcSEcCtD
Carboprost Tromethamine—Pain—Methotrexate—lung cancer	0.000414	0.000525	CcSEcCtD
Carboprost Tromethamine—Shock—Doxorubicin—lung cancer	0.000413	0.000523	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RHEB—lung cancer	0.000412	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000412	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ANXA1—lung cancer	0.000409	0.00215	CbGpPWpGaD
Carboprost Tromethamine—Tachycardia—Doxorubicin—lung cancer	0.000409	0.000519	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Doxorubicin—lung cancer	0.000405	0.000514	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000403	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ANXA1—lung cancer	0.000401	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRM8—lung cancer	0.000399	0.0021	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Docetaxel—lung cancer	0.000399	0.000506	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000397	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000392	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—lung cancer	0.000391	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRM8—lung cancer	0.000391	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000389	0.00204	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—APP—lung cancer	0.000388	0.00204	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SKI—lung cancer	0.000387	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000384	0.00201	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Methotrexate—lung cancer	0.000383	0.000485	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—lung cancer	0.000383	0.00201	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000382	0.000484	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—lung cancer	0.00038	0.002	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—APP—lung cancer	0.00038	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SKI—lung cancer	0.000378	0.00199	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Doxorubicin—lung cancer	0.000377	0.000477	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Doxorubicin—lung cancer	0.000374	0.000474	CcSEcCtD
Carboprost Tromethamine—Somnolence—Doxorubicin—lung cancer	0.000373	0.000473	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—lung cancer	0.000372	0.00195	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.00037	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000362	0.0019	CbGpPWpGaD
Carboprost Tromethamine—Pain—Doxorubicin—lung cancer	0.000359	0.000455	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Methotrexate—lung cancer	0.000357	0.000452	CcSEcCtD
Carboprost Tromethamine—Asthenia—Methotrexate—lung cancer	0.000347	0.000441	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.00034	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PXN—lung cancer	0.000336	0.00176	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000333	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AVP—lung cancer	0.000332	0.00175	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Doxorubicin—lung cancer	0.000331	0.00042	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Methotrexate—lung cancer	0.000331	0.00042	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—OXTR—lung cancer	0.000329	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKR1C1—lung cancer	0.000329	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRP—lung cancer	0.000329	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PXN—lung cancer	0.000329	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AVP—lung cancer	0.000325	0.00171	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—OXTR—lung cancer	0.000322	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRP—lung cancer	0.000322	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKR1C1—lung cancer	0.000322	0.00169	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Methotrexate—lung cancer	0.00032	0.000406	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000315	0.00165	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Doxorubicin—lung cancer	0.000309	0.000392	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000308	0.00162	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Methotrexate—lung cancer	0.000308	0.00039	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNG11—lung cancer	0.000308	0.00162	CbGpPWpGaD
Carboprost Tromethamine—Rash—Methotrexate—lung cancer	0.000305	0.000387	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methotrexate—lung cancer	0.000305	0.000387	CcSEcCtD
Carboprost Tromethamine—Headache—Methotrexate—lung cancer	0.000303	0.000385	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—lung cancer	0.000302	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AVP—lung cancer	0.000302	0.00158	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNG11—lung cancer	0.000301	0.00158	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000301	0.00158	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Doxorubicin—lung cancer	0.000301	0.000382	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—lung cancer	0.000296	0.00155	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AVP—lung cancer	0.000295	0.00155	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000295	0.00155	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFC—lung cancer	0.000293	0.00154	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Methotrexate—lung cancer	0.000288	0.000365	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Doxorubicin—lung cancer	0.000287	0.000364	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFC—lung cancer	0.000287	0.00151	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Doxorubicin—lung cancer	0.000277	0.000352	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADCY1—lung cancer	0.000277	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADCY1—lung cancer	0.000271	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PPP2R1B—lung cancer	0.00027	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SMARCA4—lung cancer	0.00027	0.00142	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Doxorubicin—lung cancer	0.000267	0.000338	CcSEcCtD
Carboprost Tromethamine—Rash—Doxorubicin—lung cancer	0.000264	0.000335	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Doxorubicin—lung cancer	0.000264	0.000335	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PPP2R1B—lung cancer	0.000264	0.00139	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SMARCA4—lung cancer	0.000264	0.00139	CbGpPWpGaD
Carboprost Tromethamine—Headache—Doxorubicin—lung cancer	0.000263	0.000333	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HSPB1—lung cancer	0.00026	0.00137	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTHLH—lung cancer	0.000257	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HSPB1—lung cancer	0.000255	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTHLH—lung cancer	0.000252	0.00132	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Doxorubicin—lung cancer	0.000249	0.000316	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ANXA1—lung cancer	0.000242	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ANXA1—lung cancer	0.000237	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FLT1—lung cancer	0.000234	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CG—lung cancer	0.000232	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APP—lung cancer	0.000229	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FLT1—lung cancer	0.000229	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH3—lung cancer	0.000229	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGF9—lung cancer	0.000227	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CG—lung cancer	0.000227	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APP—lung cancer	0.000224	0.00118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH3—lung cancer	0.000224	0.00118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGF9—lung cancer	0.000223	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—lung cancer	0.000221	0.00116	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JUNB—lung cancer	0.000217	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—lung cancer	0.000216	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JUNB—lung cancer	0.000212	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CG—lung cancer	0.000211	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CG—lung cancer	0.000206	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CD—lung cancer	0.000204	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—lung cancer	0.000201	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CD—lung cancer	0.0002	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STK11—lung cancer	0.000197	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—lung cancer	0.000196	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6R—lung cancer	0.000196	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STK11—lung cancer	0.000193	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6R—lung cancer	0.000191	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FOXO3—lung cancer	0.00019	0.000999	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAP2K1—lung cancer	0.000186	0.000979	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FOXO3—lung cancer	0.000186	0.000978	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CD—lung cancer	0.000185	0.000973	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAP2K1—lung cancer	0.000182	0.000958	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CD—lung cancer	0.000181	0.000952	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AVP—lung cancer	0.000178	0.000936	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CB—lung cancer	0.000178	0.000934	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AVP—lung cancer	0.000174	0.000916	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CB—lung cancer	0.000174	0.000914	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—lung cancer	0.000172	0.000901	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—lung cancer	0.000171	0.000897	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HES1—lung cancer	0.000169	0.000885	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—lung cancer	0.000168	0.000882	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—lung cancer	0.000167	0.000878	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAF1—lung cancer	0.000165	0.000868	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HES1—lung cancer	0.000165	0.000867	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—lung cancer	0.000163	0.000857	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAF1—lung cancer	0.000162	0.00085	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CB—lung cancer	0.000161	0.000848	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—lung cancer	0.00016	0.000839	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CB—lung cancer	0.000158	0.00083	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—lung cancer	0.000155	0.000815	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB3—lung cancer	0.000154	0.000809	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—lung cancer	0.000152	0.000798	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB3—lung cancer	0.000151	0.000792	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—lung cancer	0.000148	0.000779	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TERT—lung cancer	0.000148	0.000776	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—lung cancer	0.000145	0.000762	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TERT—lung cancer	0.000145	0.000759	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGFR1—lung cancer	0.000143	0.000753	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—lung cancer	0.000141	0.000742	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGFR1—lung cancer	0.00014	0.000737	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—lung cancer	0.000138	0.000726	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOA1—lung cancer	0.000136	0.000716	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—lung cancer	0.000135	0.00071	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOA1—lung cancer	0.000133	0.000701	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—lung cancer	0.000132	0.000695	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APC—lung cancer	0.000124	0.000654	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KIT—lung cancer	0.000124	0.000654	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—lung cancer	0.000124	0.000654	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—lung cancer	0.000124	0.000654	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGF—lung cancer	0.000123	0.000646	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—lung cancer	0.000122	0.00064	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APC—lung cancer	0.000122	0.00064	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KIT—lung cancer	0.000122	0.00064	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—lung cancer	0.000122	0.00064	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGF—lung cancer	0.00012	0.000632	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—lung cancer	0.000119	0.000626	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—lung cancer	0.000118	0.000622	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BRAF—lung cancer	0.000117	0.000614	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—lung cancer	0.000117	0.000613	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—lung cancer	0.000116	0.000609	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6R—lung cancer	0.000116	0.000607	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CREBBP—lung cancer	0.000115	0.000606	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BRAF—lung cancer	0.000115	0.000601	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—lung cancer	0.000113	0.000596	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6R—lung cancer	0.000113	0.000594	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CREBBP—lung cancer	0.000113	0.000593	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—lung cancer	0.000111	0.000583	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAP2K1—lung cancer	0.00011	0.000578	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—lung cancer	0.000109	0.000575	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—lung cancer	0.000108	0.000569	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAP2K1—lung cancer	0.000108	0.000566	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—lung cancer	0.000107	0.000563	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—lung cancer	0.000107	0.000562	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—lung cancer	0.000106	0.000557	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—lung cancer	0.000105	0.000551	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—lung cancer	9.84e-05	0.000517	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MDM2—lung cancer	9.8e-05	0.000515	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAF1—lung cancer	9.77e-05	0.000513	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—lung cancer	9.66e-05	0.000508	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—lung cancer	9.63e-05	0.000506	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MDM2—lung cancer	9.59e-05	0.000504	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAF1—lung cancer	9.56e-05	0.000502	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—lung cancer	9.54e-05	0.000501	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MTOR—lung cancer	9.54e-05	0.000501	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—lung cancer	9.46e-05	0.000497	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MTOR—lung cancer	9.33e-05	0.00049	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—lung cancer	9.33e-05	0.00049	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—lung cancer	9.16e-05	0.000481	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—lung cancer	9.1e-05	0.000478	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—lung cancer	8.97e-05	0.000471	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—lung cancer	8.91e-05	0.000468	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—lung cancer	8.85e-05	0.000465	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—lung cancer	8.77e-05	0.000461	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—lung cancer	8.76e-05	0.00046	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—lung cancer	8.71e-05	0.000458	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—lung cancer	8.67e-05	0.000455	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—lung cancer	8.59e-05	0.000451	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—lung cancer	8.57e-05	0.00045	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCND1—lung cancer	8.54e-05	0.000448	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—lung cancer	8.53e-05	0.000448	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JUN—lung cancer	8.52e-05	0.000447	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCND1—lung cancer	8.36e-05	0.000439	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JUN—lung cancer	8.34e-05	0.000438	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—lung cancer	8.29e-05	0.000435	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—lung cancer	8.26e-05	0.000434	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTEN—lung cancer	8.24e-05	0.000433	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—lung cancer	8.11e-05	0.000426	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—lung cancer	8.08e-05	0.000425	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTEN—lung cancer	8.07e-05	0.000424	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—lung cancer	8.04e-05	0.000422	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—lung cancer	7.87e-05	0.000413	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EP300—lung cancer	7.86e-05	0.000413	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EP300—lung cancer	7.69e-05	0.000404	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SRC—lung cancer	7.64e-05	0.000401	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SRC—lung cancer	7.48e-05	0.000393	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—lung cancer	7.44e-05	0.000391	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—lung cancer	7.37e-05	0.000387	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NRAS—lung cancer	7.35e-05	0.000386	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—lung cancer	7.29e-05	0.000383	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—lung cancer	7.21e-05	0.000379	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NRAS—lung cancer	7.2e-05	0.000378	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—lung cancer	7.04e-05	0.00037	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—lung cancer	6.89e-05	0.000362	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—lung cancer	6.85e-05	0.00036	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—lung cancer	6.7e-05	0.000352	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—lung cancer	6.7e-05	0.000352	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—lung cancer	6.56e-05	0.000344	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KRAS—lung cancer	6.33e-05	0.000332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KRAS—lung cancer	6.19e-05	0.000325	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—lung cancer	5.81e-05	0.000305	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—lung cancer	5.69e-05	0.000299	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—lung cancer	5.62e-05	0.000295	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—lung cancer	5.5e-05	0.000289	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRAS—lung cancer	5.38e-05	0.000282	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRAS—lung cancer	5.26e-05	0.000277	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—lung cancer	5.15e-05	0.00027	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—lung cancer	5.04e-05	0.000265	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—lung cancer	4.75e-05	0.000249	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—lung cancer	4.65e-05	0.000244	CbGpPWpGaD
